Inventor

Flynn Michael Allen

US6 patents

⚠️ This page may combine multiple inventors who share the name “Flynn Michael Allen”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AERPIO THERAPEUTICS LLC

2 patents

US10604569B2Mar 31, 2020

Humanized monoclonal antibodies that target protein tyrosine phosphatase-beta (HPTP-β/VE-PTP)

AERPIO THERAPEUTICS LLC12 citations92

US10597452B2Mar 24, 2020

Methods of treating ocular conditions by administering humanized monoclonal antibodies that target VE-PTP (HPTP-beta)

AERPIO THERAPEUTICS LLC11 citations92

EYEPOINT PHARMACEUTICALS INC

2 patents

US11180551B2Nov 23, 2021

Humanized monoclonal antibodies that target VE-PTP (HPTP-beta)

EYEPOINT PHARMACEUTICALS INC6 citations82

US12145986B2Nov 19, 2024

Method of treating an ocular condition by administering a humanized monoclonal antibodies that target VE-PTP (HPTP-Beta)

EYEPOINT PHARMACEUTICALS INC1 citations71

AERPIO THERAPEUTICS INC

1 patent

US10253094B2Apr 9, 2019

Antibodies that target human protein tyrosine phosphatase-beta (HPTP-beta) and methods of use thereof to treat ocular conditions

AERPIO THERAPEUTICS INC13 citations91

AERPIO PHARMACEUTICALS INC

1 patent

US11136389B2Oct 5, 2021

Humanized monoclonal antibodies that target VE-PTP (HPTP-β)

AERPIO PHARMACEUTICALS INC5 citations82